These include breaks in humoral tolerance that result in the production of autoimmune antibodies; inflammation typically characterized by increased levels of Type I cytokines, such as interferon alpha (IFNα); and, lupus-induced kidney damage, known as lupus nephritis. Here, IFNA1 is linked to systemic lupus erythematosus.